Biopsy Location for Direct Immunofluorescence in Patients with Suspected Bullous Pemphigoid Impacts Probability of a Positive Test Result

Abstract

French

Background:

Bullous pemphigoid (BP) is an autoimmune polymorphic skin disease characterized by erythematous papules and plaques and tense bullae. A skin biopsy for direct immunofluorescence (DIF) is used to detect autoantibodies and complement proteins.

Objective:

We sought to determine which location would provide the highest probability of obtaining a positive DIF result.

Method:

We undertook a retrospective chart review of 1,423 DIF biopsies. Biopsies with a clinical suspicion of BP were designated as either lesional, perilesional, or indeterminate.

Results:

Fifty percent of lesional DIF biopsies were positive, whereas 22% of perilesional and 12% of indeterminate biopsies had a positive DIF result. The odds ratio of a positive DIF from a lesional versus perilesional biopsy site was found to be 3.45 (95% CI 1.44–8.29).

Conclusion:

Clinicians are more likely to obtain a positive DIF result from a lesional nonbullous skin biopsy than from a perilesional or normal skin biopsy.

Get full access to this article

View all access options for this article.

References

Schmidt

Zillikens

. Pemphigoid diseases. Lancet 2013;381:320–32, doi:10.1016/S0140-6736(12)61140-4.

Schmidt

Della

Borradori

. Clinical features and practical diagnosis of bullous pemphigoid. Immunol Allergy Clin North Am 2012;32:217–32, v, doi:10.1016/j.iac.2012.04.002.

Chaidemenos

Maltezos

Chrysomallis

. Value of routine diagnostic criteria of bullous pemphigoid. Int J Dermatol 1998;37:206–10, doi:10.1046/j.1365-4362.1998.00271.x.

Weigand

Clements

. Direct immunofluorescence in bullous pemphigoid: effects of extent and location of lesions. J Am Acad Dermatol 1989;20:437–40, doi:10.1016/S0190-9622(89)70054-2.

Anstey

Venning

Wojnarowska

. Determination of the optimum site for diagnostic biopsy for direct immunofluorescence in bullous pemphigoid. Clin Exp Dermatol 1990;15:438–41, doi:10.1111/j.1365-2230.1990.tb02139.x.

Goldberg

Sabolinski

Bystryn

. Regional variation in the expression of bullous pemphigoid antigen and location of lesions in bullous pemphigoid. J Invest Dermatol 1984;82:326–8, doi:10.1111/1523-1747.ep12260627.

Pohla-Gubo

Hintner

. Direct and indirect immunofluorescence for the diagnosis of bullous autoimmune diseases. Dermatol Clin 2011;29:365–72, vii, doi:10.1016/j.det.2011.03.001.

Weigand

. Effect of anatomic region on immunofluorescence diagnosis of bullous pemphigoid. J Am Acad Dermatol 1985;12 (2 Pt 1):274–8, doi:10.1016/S0190-9622(85)80035-9.